The Antioxidant, Anti-Inflammatory, and Neuroprotective Properties of the Synthetic Chalcone Derivative AN07Chen · Molecular Diversity Preservation International2020PDF3.6 MB
A 2-year Open-label Study of Botulinum Toxin Type B in Botulinum Toxin Type A Resistant/responsive Cervical Dystonia Patients (AN072-401 EU/CD)Peter · Toxicon2008PDF40 KB
The effects of repeated dosing of botulinum toxin type B (neurobloc®) in patients with cervical dystonia previously naïve to botulinum toxin: An open-label extension study (AN072-402 EU/CD)Joaquim · Toxicon2008PDF41 KB
Botulinum Toxin Type A (Botox) Versus Botulinum Toxin Type B (Myobloc) in Subjects with Cervical Dystonia: A Comparison of the Frequency of Xerostomia and Dysphagia (AN072-402 EU/CD)Eric · Toxicon2008PDF42 KB
Is Treatment of Cervical Dystonia Patients with Botulinum Toxin Type B Affected by a Previous Response to a Botulinum Toxin Type A? Analysis of a Long-term Open-label Study (AN072-401 EU/CD)Peter · Toxicon2008PDF40 KB
